These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 30074311)
1. Percutaneous radiofrequency ablation for symptomatic uterine leiomyomas: a systematic review and meta-analysis. Lim KJ; Yoon DY; Kim J H ; Cho YK; Kim HJ; Ahn HS; Ahn IM Clin Exp Obstet Gynecol; 2016; 43(5):643-649. PubMed ID: 30074311 [TBL] [Abstract][Full Text] [Related]
2. Uterine Leiomyomas: Safety and Efficacy of US-guided Suprapubic Transvaginal Radiofrequency Ablation at 1-year Follow-up. Wu XJ; Guo Q; Cao BS; Tan LX; Zhang HY; Cai YR; Gao BL Radiology; 2016 Jun; 279(3):952-60. PubMed ID: 26694049 [TBL] [Abstract][Full Text] [Related]
3. Clinical Performance of Radiofrequency Ablation for Treatment of Uterine Fibroids: Systematic Review and Meta-Analysis of Prospective Studies. Bradley LD; Pasic RP; Miller LE J Laparoendosc Adv Surg Tech A; 2019 Dec; 29(12):1507-1517. PubMed ID: 31702440 [No Abstract] [Full Text] [Related]
4. Quality of Life, Adverse Events, and Reintervention Outcomes after Laparoscopic Radiofrequency Ablation for Symptomatic Uterine Fibroids: A Meta-Analysis. Lin L; Ma H; Wang J; Guan H; Yang M; Tong X; Zou Y J Minim Invasive Gynecol; 2019; 26(3):409-416. PubMed ID: 30253997 [TBL] [Abstract][Full Text] [Related]
5. Laparoscopic Radiofrequency Ablation of Uterine Leiomyomas: Clinical Outcomes during Early Adoption into Surgical Practice. Jacoby VL; Parvataneni R; Oberman E; Saberi NS; Varon S; Schembri M; Waetjen LE J Minim Invasive Gynecol; 2020; 27(4):915-925. PubMed ID: 31376584 [TBL] [Abstract][Full Text] [Related]
6. Radiofrequency Thermal Ablation for Uterine Myomas: Long-term Clinical Outcomes and Reinterventions. Iversen H; Dueholm M J Minim Invasive Gynecol; 2017; 24(6):1020-1028. PubMed ID: 28662989 [TBL] [Abstract][Full Text] [Related]
15. Three-year outcome of the Halt trial: a prospective analysis of radiofrequency volumetric thermal ablation of myomas. Berman JM; Guido RS; Garza Leal JG; Pemueller RR; Whaley FS; Chudnoff SG; J Minim Invasive Gynecol; 2014; 21(5):767-74. PubMed ID: 24613404 [TBL] [Abstract][Full Text] [Related]
16. Ultrasound-guided transvaginal radiofrequency myolysis for symptomatic uterine myomas. Jiang X; Thapa A; Lu J; Bhujohory VS; Liu Y; Qiao S Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():38-43. PubMed ID: 24766899 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of ultrasound-guided percutaneous microwave ablation for symptomatic uterine fibroids: a multicentre study in China. Liu H; Zhang J; Han ZY; Zhang BS; Zhang W; Qi CS; Yu SY; Li HZ; Su HH; Duan XM; Li QY; Li XM; Xu RF Int J Hyperthermia; 2016 Dec; 32(8):876-880. PubMed ID: 27405972 [TBL] [Abstract][Full Text] [Related]
19. Comparison between radiofrequency ablation combined with mifepristone and radiofrequency ablation for large uterine fibroids. Hai N; Hou Q; Dong X; Guo R Int J Hyperthermia; 2021; 38(1):777-780. PubMed ID: 33980123 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of transvaginal high-intensity focused ultrasound therapy in women with symptomatic uterine leiomyomas: A clinical trial. Lee JY; Kim K; Hwang SI; Lee M; Son K; Kim D; Kim S; Kim YB Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():302-307. PubMed ID: 33259999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]